The Mesothelioma pathophysiology overview
Mesothelioma is a rare and aggressive form of cancer that primarily affects the mesothelium, a thin layer of tissue lining the lungs, chest wall, abdomen, and other internal organs. Understanding its pathophysiology is crucial for developing effective diagnostic tools and treatments. The development of mesothelioma is closely linked to asbestos exposure, which introduces asbestos fibers into the body, initiating a complex cascade of cellular and molecular events.
When asbestos fibers are inhaled or ingested, they become lodged within the mesothelial tissue. These fibers are highly durable and resistant to breakdown, persisting in the tissue for decades. The physical presence of asbestos fibers causes direct mechanical injury to mesothelial cells, leading to cellular stress and injury. This damage triggers a chronic inflammatory response characterized by the infiltration of immune cells such as macrophages, lymphocytes, and neutrophils. These immune cells attempt to clear the fibers but often fail, leading to prolonged inflammation.
A significant aspect of mesothelioma pathophysiology involves the interaction between asbestos fibers and mesothelial cells, which results in the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS). These reactive molecules cause oxidative stress, damaging cellular DNA, proteins, and lipids. The persistent DNA damage can induce mutations in critical genes that regulate cell growth and apoptosis, such as tumor suppressor genes (e.g., BAP1, p53) and oncogenes.
Over time, the accumulation of genetic mutations disrupts normal cellular regulation, leading to uncontrolled proliferation of mesothelial cells. These transformed cells acquire the ability to evade apoptosis, sustain proliferative signaling, and promote angiogenesis—all hallmarks of cancer. The tumor microenvironment further facilitates mesothelioma progression by secreting growth factors, cytokines, and extracellular matrix components that support tumor growth, invasion, and metastasis.
On a molecular level, mesothelioma exhibits alterations in multiple signaling pathways, including the NF-κB pathway, which promotes inflammation and cell survival, and the PI3K/Akt pathway, which supports cellular growth and resistance to apoptosis. These molecular changes underpin the aggressive nature of mesothelioma and complicate treatment efforts.
In addition to genetic mutations, epigenetic modifications such as DNA methylation and histone modifications play roles in mesothelioma development, affecting gene expression without altering the DNA sequence. These changes can further promote oncogenic pathways and resistance to therapy.
In summary, the pathophysiology of mesothelioma involves a multifaceted process initiated by asbestos fiber exposure, leading to persistent inflammation, oxidative DNA damage, genetic and epigenetic alterations, and ultimately malignant transformation of mesothelial cells. Understanding these mechanisms is essential for advancing early detection and developing targeted therapies to improve patient outcomes.